3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Breast
15
Gastrointestinal
13
Genitourinary
11
Other hematologic neoplasm
7
Gynecologic
7
Lymphoid
5
CNS
5
Endocrine
4
Dermatologic
3
Classical hematology
3
Thoracic
2
NET
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
191
Anemia, Refractory, with Excess of Blasts
179
Myelodysplastic Syndromes
175
Leukemia
168
Precursor Cell Lymphoblastic Leukemia-Lymphoma
132
Neoplasms
121
Multiple Myeloma
116
Venous Thromboembolism
111
Anemia
108
Leukemia, Myelomonocytic, Chronic
103
Leukemia, Lymphocytic, Chronic, B-Cell
100
Myeloproliferative Disorders
99
Lymphoma, Non-Hodgkin
97
Lymphoma
96
Hodgkin Disease
85
Thrombocytopenia
84
Anemia, Aplastic
79
Primary Myelofibrosis
67
Lymphoma, Follicular
67
Hematologic Neoplasms
63
Leukemia, Myeloid, Chronic-Phase
61
Lymphoma, Mantle-Cell
59
Febrile Neutropenia
59
Congenital Abnormalities
59
Neoplasms, Plasma Cell
57
Leukemia, Myeloid, Accelerated Phase
57
Anemia, Refractory
57
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
56
Blast Crisis
56
Burkitt Lymphoma
53
Interventions
Cognitive Behavioral Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Genetic Predisposition to Disease
×
Classical hematology
×
Clear all
NCT03050268
2026-04-23
SJFAMILY
St. Jude Children's Research Hospital
Recruiting
1,500 enrolled
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled
NCT01346761
2016-04-14
REACH
University of Utah
Phase NA
Completed
1,012 enrolled